Demo Sign up Log In

Vertex Pharmaceuticals (VRTX)

Long-Term Debt

$1.98B

Quarterly · Period ending: Jun 30, 2026 · USD

VRTX Long-Term Debt

Latest reported$1.98Bperiod endingJun 30, 2026

Latest reported$1.98Bperiod endingJun 30, 2026

VRTX Quarterly Long-Term Debt ($2.40M → $1.98B)

Quarterly long-term debt

High-resolution chart · PNG

VRTX long-term debt history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Vertex Pharmaceuticals Long-Term Debt — Quarterly (USD)
Period ending	Long-Term Debt (USD)
Jun 30, 2001	346,633,000
Mar 31, 2001	346,966,000
Dec 31, 2000	357,269,000
Sep 30, 2000	348,121,000
Jun 30, 2000	178,619,000
Mar 31, 2000	179,155,000
Dec 31, 1999	4,693,000
Sep 30, 1999	5,300,000
Jun 30, 1999	5,800,000
Mar 31, 1999	6,400,000
Dec 31, 1998	7,000,000
Sep 30, 1998	7,600,000
Jun 30, 1998	6,900,000
Mar 31, 1998	6,200,000
Dec 31, 1997	5,900,000
Sep 30, 1997	5,500,000
Jun 30, 1997	5,400,000
Mar 31, 1997	5,300,000
Dec 31, 1996	5,600,000
Sep 30, 1996	4,400,000
Jun 30, 1996	4,600,000
Mar 31, 1996	4,400,000
Dec 31, 1995	4,900,000
Sep 30, 1995	4,900,000
Jun 30, 1995	5,100,000
Mar 31, 1995	4,900,000
Dec 31, 1994	4,700,000
Sep 30, 1994	4,700,000
Jun 30, 1994	4,400,000
Mar 31, 1994	3,900,000
Dec 31, 1993	4,200,000
Sep 30, 1993	4,000,000
Jun 30, 1993	3,900,000
Mar 31, 1993	3,400,000
Dec 31, 1992	3,300,000
Sep 30, 1992	3,300,000
Jun 30, 1992	2,900,000
Mar 31, 1992	2,300,000
Dec 31, 1991	2,100,000
Sep 30, 1991	2,400,000
Jun 30, 1991	2,500,000
Dec 31, 1990	2,400,000

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.